NCT02690038 - Ig PRx in AECOPD: Pilot Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 20, 2019

Study Completion Date

November 20, 2019

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Intravenous immunoglobulin (IVIG)

"Baseline Ig \< 7g/L group - Intravenous immunoglobulin (IVIG) 0.8 g/kg will be given within 12 hours after randomization.~Baseline Ig \> or = 7 g/L group - Intravenous immunoglobulin (IVIG) 0.5 g/kg will be given within 12 hours after randomization"

DRUG

Normal Saline

"Baseline Ig \< 7g/L group - Normal Saline (0.9% NaCl) 8 mL/kg will be given within 12 hours after randomization.~Baseline Ig \> or = 7 g/L group - Normal Saline (0.9% NaCl) 5 mL/kg will be given within 12 hours after randomization"

Trial Locations (1)

K1H 8L6

The Ottawa Hospital, General Campus, Ottawa